A low-cost Ayurvedic medicine has been developed by the Council for Scientific and Industrial Research (CSIR) along with two other organizations for diabetes patients.
The medicine named "BGR-34" has been developed jointly by CSIR-NBRI (National Botanical Research Institute) Lucknow and CSIR-CIMAP (Central Institute of Medicinal & Aromatic Plants (Lucknow).
The medicine was launched here yesterday at the presence of A K S Rawat-Principal Senior Scientist CSIR- National Botanical Research Institute, Lucknow and D N Mani Senior Scientist CSIR-Central Institute for Medicinal And Aromatic Plants, Lucknow.
It would help maintain normal Blood Glucose Metabolism and also reduce chances of long term complications, they said.
AIMIL Pharmaceuticals, a private company, has been given the marketing right of the Ayurvedic proprietary medicine, a company release said.
